{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:51:53Z","timestamp":1791647513945,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.anai.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T18:54:52Z","timestamp":1628880892000},"page":"674-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine"],"prefix":"10.1016","volume":"127","author":[{"given":"Hsing-Jou","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-0959","authenticated-orcid":false,"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anai.2021.08.012_bib0001","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.anai.2021.08.012_bib0002","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.anai.2021.08.012_bib0003","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.012_bib0004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaip.2016.11.027","article-title":"Virus reactivation in drug reaction with eosinophilia and systemic symptoms (dress) results from a strong drug-specific immune response","volume":"5","author":"Roujeau","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2021.08.012_bib0005","doi-asserted-by":"crossref","first-page":"709.e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"10106","key":"10.1016\/j.anai.2021.08.012_bib0006","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anai.2021.08.012_bib0007","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.012_bib0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsi.2013.09.004","article-title":"Long-term outcome of patients with severe cutaneous adverse reactions","volume":"31","author":"Kano","year":"2013","journal-title":"Dermatol Sin"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Life-threatening acute adverse cutaneous drug reactions","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamadermatol.2013.6698","article-title":"Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features","volume":"150","author":"Tetart","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2021.08.012_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.anai.2021.08.012_bib0012","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.012_bib0013","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2230.2003.01267.x","article-title":"Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin","volume":"28","author":"Harman","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CNP64155","article-title":"Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment","volume":"64","author":"Zuliani","year":"2005","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.012_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0016","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4103\/ijdvl.IJDVL_1084_16","article-title":"Treatment of drug-induced hypersensitivity syndrome with cyclosporine","volume":"83","author":"Zhang","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"10.1016\/j.anai.2021.08.012_bib0017","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","article-title":"Cyclosporine treatment of drug-induced hypersensitivity syndrome","volume":"152","author":"Kirchhof","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0018","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.012_bib0019","doi-asserted-by":"crossref","first-page":"638.e1","DOI":"10.1016\/j.ajem.2011.02.018","article-title":"Acute myocardial infarction in a 56-year-old female patient treated with sulfasalazine","volume":"30","author":"Daoulah","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.anai.2021.08.012_bib0022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","article-title":"Therapeutic management of DRESS: a retrospective study of 38 cases","volume":"72","author":"Funck-Brentano","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.012_bib0023","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2021.08.012_bib0024","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","article-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update","volume":"206","author":"Tas","year":"2003","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.anai.2021.08.012_bib0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0026","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.anai.2021.08.012_bib0027","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches","volume":"137","author":"Gonz\u00e1lez-Herrada","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0028","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0029","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/bjd.17587","article-title":"British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018","volume":"180","author":"Berth-Jones","year":"2019","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.anai.2021.08.012_bib0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anai.2021.08.012_bib0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","article-title":"The mechanism of action of FK-506 and cyclosporin A","volume":"696","author":"Wiederrecht","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.anai.2021.08.012_bib0032","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.08.012_bib0033","first-page":"645","article-title":"[Cyclosporin A inhibits interleukin 5 (IL-5) production from human peripheral lymphocytes]","volume":"43","author":"Kimura","year":"1994","journal-title":"Arerugi"},{"issue":"1","key":"10.1016\/j.anai.2021.08.012_bib0034","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:33Z","timestamp":1761053253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621005706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1081120621005706"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}